指南与共识乳腺癌放疗

加速部分乳腺照射:ASTRO循证共识声明更新执行摘要

Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement.
指南 / 共识 · Pract Radiat Oncol · 2016-09-17

该更新基于系统检索的419篇文献中选出的44篇,结合专家意见修订2009年ASTRO加速部分乳腺照射共识。主要更新包括将「适合组」年龄下限从60岁降至50岁、「谨慎组」降至40岁,低风险导管原位癌归入「适合组」,并对术中放疗(IORT)的使用提出具体推荐。

要点

  • 「适合组」年龄下限从60岁降至50岁,「谨慎组」降至40岁。
  • 符合RTOG 9804标准的低风险导管原位癌归入「适合组」。
  • IORT须告知同侧乳腺肿瘤复发风险高于全乳照射,仅限「适合」的浸润性癌。

核心结论

  • 更新后的共识为放射肿瘤科及其他参与乳腺癌治疗的专科医生提供加速部分乳腺照射的临床指导。

研究设计与样本

  • 通过系统PubMed检索,使用与原共识声明相同的检索词,共获得419篇文章,最终选取44篇。
  • 作者综合已发表证据,并通过系列电话会议和电子邮件达成共识推荐。

主要发现

  • 「适合组」年龄下限从60岁降至50岁,「谨慎组」降至40岁,适用于满足所有其他适合性要素的患者。
  • 符合RTOG 9804标准的低风险导管原位癌被归入「适合」组。
  • 工作组同意维持基于切缘状态的现有标准。

关键数值与推荐

  • IORT推荐包括:须告知患者IORT相比全乳照射有更高的同侧乳腺肿瘤复发风险。
  • 鉴于随访有限,低能X线IORT需前瞻性监测长期局部控制与毒性。
  • IORT仅限于被认为「适合」的浸润性癌女性。

临床怎么用

  • 放射肿瘤科医生可依据更新后的年龄与病理标准筛选加速部分乳腺照射的适合患者。
  • 使用IORT时须充分告知同侧乳腺肿瘤复发风险,并限制于「适合」的浸润性癌患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To update the accelerated partial breast irradiation Consensus Statement published in 2009 and provide guidance on use of intraoperative radiation therapy (IORT) for partial breast irradiation in early-stage breast cancer, based on published evidence complemented by expert opinion. METHODS AND MATERIALS: A systematic PubMed search using the same terms as the original Consensus Statement yielded 419 articles; 44 articles were selected. The authors synthesized the published evidence and, through a series of conference calls and e-mails, reached consensus regarding the recommendations. RESULTS: The new recommendations include lowering the age in the "suitability group" from 60 to 50 years and in the "cautionary group" to 40 years for patients who meet all other elements of suitability (Table 1). Patients with low-risk ductal carcinoma in situ, as per Radiation Therapy Oncology Group 9804 criteria, were categorized in the "suitable" group. The task force agreed to maintain the current criteria based on margin status. Recommendations for the use of IORT for breast cancer patients include: counseling patients regarding the higher risk of ipsilateral breast tumor recurrence with IORT compared with whole breast irradiation; the need for prospective monitoring of long-term local control and toxicity with low-energy radiograph IORT given limited follow-up; and restriction of IORT to women with invasive cancer considered "suitable." CONCLUSION: These recommendations will provide updated clinical guidance regarding use of accelerated partial breast irradiation for radiation oncologists and other specialists participating in the care of breast cancer patients.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Correa C, Harris EE, Leonardi MC, et al. Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement. Pract Radiat Oncol. 2016. PMID: 27866865. doi:10.1016/j.prro.2016.09.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。